Neuronetics, Inc. (FRA:NRC)
Germany flag Germany · Delayed Price · Currency is EUR
1.128
+0.038 (3.49%)
At close: Dec 4, 2025

Neuronetics Company Description

Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally.

The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder.

Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood.

The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Neuronetics, Inc.
Country United States
Founded 2001
Industry Electromedical and Electrotherapeutic Apparatus
Employees 716
CEO Keith Sullivan

Contact Details

Address:
3222 Phoenixville Pike
Malvern, Delaware 19355
United States
Phone 610 640 4202
Website neurostar.com

Stock Details

Ticker Symbol NRC
Exchange Frankfurt Stock Exchange
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
SIC Code 3845

Key Executives

Name Position
Keith Sullivan Chief Executive Officer
Steven Pfanstiel Chief Financial Officer
Jeffrey Jones Chief Operating Officer